Quantum-Si Incorporated received a written notice from Nasdaq on July 23, 2026, stating the company is non-compliant with the minimum bid price requirement. The Class A common stock's closing bid price fell below $1.00 for 30 consecutive business days. The company has an initial 180-day period, ending January 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days. Failure to comply may lead to a transfer to the Nasdaq Capital Market or delisting. Quantum-Si is a biotechnology company providing protein sequencing solutions.

Quantum-Si, Incorporated entered into a 120-month lease agreement with Sterling City Science South Development, LLC for approximately 54,374 square feet of office, laboratory, and manufacturing space in San Diego, California. The lease term is expected to commence on or about September 1, 2027, with an initial monthly base rent of approximately $315,369.20, featuring a 20-month rent abatement period and a $17,127,810.00 tenant improvement allowance. Quantum-Si is a biotechnology company that develops Proteus&TM platform technology for protein sequencing. } ]